Rare diseases
Investigational molecules
Locations
Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
CzechiaPhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
CzechiaLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
CzechiaOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
CzechiaLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
CzechiaA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
CzechiaA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
CzechiaA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
CzechiaA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
CzechiaA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
CzechiaStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
CzechiaStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
